| Literature DB >> 32943933 |
Shao-Hao Chen1, Zhi-Bin Ke1, Yu-Peng Wu1, Dong-Ning Chen1, Xiang Yu1, Yu Chen2,3, Yong Wei1, Qing-Shui Zheng1, Xue-Yi Xue1, Ning Xu1.
Abstract
PURPOSE: To identify the relevant factors, and create and validate a predictive scoring system for the duration of laparoscopic radical prostatectomy (LRP). PATIENTS AND METHODS: We retrospectively analyzed clinicopathological data from 436 patients who underwent LRP between January 2014 and January 2019, of whom 304 cases were used as a model creation group and 132 were used as a validation group. Uni/multivariate linear regression analysis was performed to determine the predictors of the duration of the procedure and a novel scoring system was created using these predictors. External validation of the scoring system was performed. The Hosmer-Lemeshow test was used to determine the goodness-of-fit of the model and calibration plots were created for visual assessment.Entities:
Keywords: intravesical protrusion of prostate; neurovascular bundle preservation; pelvic lymph node dissection; predictive factor; prostate cancer; prostate volume
Year: 2020 PMID: 32943933 PMCID: PMC7481309 DOI: 10.2147/CMAR.S265480
Source DB: PubMed Journal: Cancer Manag Res ISSN: 1179-1322 Impact factor: 3.989
Characteristics of the Model Creation and Validation Groups
| Variables | Mean or Median ± SD or n (%) | |
|---|---|---|
| Model Building Group | Validation Group | |
| Age (year) | 66.78±6.53 | 67.30±7.06 |
| Prostate volume (mL) | 44.32±18.34 | 45.63±18.61 |
| tPSA (ng/mL) | 16.01±11.81 | 14.72±10.56 |
| BMI (Kg/m2) | 24.12±2.90 | 23.88±3.01 |
| P/R | 0.68±0.10 | 0.67±0.10 |
| IPP (mm) | 8.52±4.27 | 8.15±4.53 |
| ISD (cm) | 9.63±0.78 | 9.60±0.85 |
| ITD (cm) | 11.55±0.91 | 11.52±0.95 |
| MAD (cm) | 10.00±1.61 | 9.96±1.44 |
| OAD (cm) | 8.14±1.28 | 8.07±1.41 |
| PAD (cm) | 3.06±0.48 | 3.03±0.59 |
| ISD/PAD | 3.22±0.57 | 3.30±0.77 |
| cT Stage | ||
| T1c | 125 (41.11) | 52 (39.39) |
| T2a | 42 (13.82) | 18 (13.64) |
| T2b | 37 (12.17) | 15 (11.36) |
| T2c | 78 (25.66) | 35 (26.52) |
| ≥T3a | 22 (7.24) | 12 (9.09) |
| ISUP Groupe | ||
| Groupe 1 | 103 (27.30) | 32 (24.24) |
| Groupe 2 | 70 (24.01) | 28 (21.21) |
| Groupe 3 | 66 (22.70) | 29 (21.97) |
| Groupe 4 | 36 (13.16) | 20 (15.15) |
| Groupe 5 | 29 (12.83) | 23 (17.42) |
| Hypertension | ||
| Yes | 133 (43.75) | 57 (43.18) |
| No | 171 (56.25) | 75 (56.82) |
| Diabetes | ||
| Yes | 72 (23.68) | 27 (20.45) |
| No | 232 (76.32) | 105 (79.55) |
| Pelvic lymph node dissection | ||
| Yes | 210 (69.08) | 94 (71.21) |
| No | 94 (30.92) | 38 (28.79) |
| NVB preservation | ||
| Yes | 214 (70.39) | 86 (65.15) |
| No | 90 (29.61) | 46 (34.85) |
| Surgical approach | ||
| transperitoneal | 77 (25.33) | 26 (19.70) |
| extraperitoneal | 227 (74.67) | 106 (80.30) |
| Previous abdominal surgery | ||
| Yes | 45 (14.80) | 17 (12.88) |
| No | 259 (85.20) | 115 (87.12) |
| Operative time (min) | 150.53±45.52 | 163.27±49.33 |
Abbreviations: BMI, body mass index; IPP, intravesicular protrusion of the prostate; ISD, narrowest distance between the tips of the ischial spines; ISUP, International Society of Urological Pathology; ITD, widest distance between the ischial tuberosities; MAD, anteroposterior diameter of the pelvis at the mid-plane; NVB, neurovascular bundle; OAD, anteroposterior diameter of the pelvic outlet; PAD, depth of the prostatic apex; P/R: ratio of the cross-sectional areas of the prostate and the Retzius space; tPSA, total prostate-specific antigen.
Figure 1(A) The cross-sectional area of the Retzius space was defined as the area surrounded by the pubic bone, levator ani, and rectum on an MRI image, as shown by the red line. The cross-sectional area of the prostate is shown by the blue line. (B) The sagittal section of prostate on an MRI image. (a) IPP: the distance from the deepest part of prostatic protrusion into the bladder to the level of the bladder neck on the sagittal plane of the MRI image. The red double arrow refers to IPP.
Figure 2(A, B)The cross section and (C) sagittal section of prostate on an MRI image. (a) ISD: the narrowest distance between the tips of the ischial spines; (b) ITD: the widest distance between the ischial tuberosities at the pelvic outlet; (c) PAD: the vertical distance from the closest edge of the pubic symphysis to the distal edge of the prostatic tip on the sagittal plane of the MRI image; (d) MAD: the anteroposterior diameter of the pelvis at the mid-plane; and (e) OAD: the anteroposterior diameter of the pelvic outlet (distances indicated with red arrows).
Univariate Linear Regression Analysis of the Factors Potentially Affecting the Total Duration of Surgery
| Variables | t | p |
|---|---|---|
| Age | −0.074 | 0.941 |
| BMI | 13.505 | <0.001 |
| Hypertension | −0.081 | 0.935 |
| Diabetes | −0.455 | 0.649 |
| tPSA | −4.65 | 0.642 |
| Prostate volume | 17.817 | <0.001 |
| cT Stage | 0.764 | 0.431 |
| Previous abdominal surgery | 0.423 | 0.673 |
| ISUP Groupe | −1.200 | 0.231 |
| Surgical approach | 2.361 | 0.019 |
| Pelvic lymph node dissection | 3.390 | 0.001 |
| NVB preservation | 4.828 | <0.001 |
| IPP | 14.590 | <0.001 |
| P/R | 9.853 | <0.001 |
| ISD | 0.619 | 0.536 |
| ITD | 1.699 | 0.090 |
| MAD | −0.445 | 0.657 |
| OAD | −1.726 | 0.085 |
| PAD | 0.432 | 0.666 |
| ISD/PAD | −0.455 | 0.649 |
Abbreviations: BMI, body mass index; IPP, intravesicular protrusion of the prostate; ISD, narrowest distance between the tips of the ischial spines; ISUP, International Society of Urological Pathology; ITD, widest distance between the ischial tuberosities; MAD, anteroposterior diameter of the pelvis at the mid-plane; NVB, neurovascular bundle; OAD, anteroposterior diameter of the pelvic outlet; PAD, depth of the prostatic apex; P/R: ratio of the cross-sectional areas of the prostate and the Retzius space; tPSA, total prostate-specific antigen.
Multivariate Linear Regression Analysis of Factors Potentially Affecting the Total Duration of Surgery
| Variables | Unstandardized Coefficients | Standardized Coefficients | t | P | |
|---|---|---|---|---|---|
| β | Std. Error | Beta | |||
| (Constant) | −35.084 | 16.553 | −2.120 | 0.035 | |
| BMI | 2.727 | 0.712 | 0.174 | 3.830 | <0.001 |
| Prostate volume | 1.012 | 0.112 | 0.408 | 9.000 | <0.001 |
| Surgical approach (transperitoneal vs extraperitoneal) | 4.291 | 3.791 | 0.041 | 1.132 | 0.259 |
| Pelvic lymph node dissection | 7.961 | 3.650 | 0.081 | 2.181 | 0.030 |
| NVB preservation | 9.887 | 3.586 | 0.099 | 2.757 | 0.006 |
| IPP | 21.220 | 5.013 | 0.199 | 4.233 | <0.001 |
| P/R | 63.728 | 18.827 | 0.133 | 3.385 | 0.001 |
Abbreviations: BMI, body mass index; IPP, intravesicular protrusion of the prostate; NVB, neurovascular bundle; P/R, ratio of the cross-sectional areas of the prostate and the Retzius space.
Scoring System for the Prediction of Prolonged LRP
| Parameters | Score | |
|---|---|---|
| BMI (Kg/m2) | ≥24.12 | 1 |
| <24.12 | 0 | |
| Prostate volume (mL) | ≥44.32 | 1 |
| <44.32 | 0 | |
| Pelvic lymph node dissection | Yes | 1 |
| No | 0 | |
| NVB preservation | Yes | 1 |
| No | 0 | |
| IPP (mm) | ≥8.52 | 1 |
| <8.52 | 0 | |
| P/R | ≥0.68 | 1 |
| <0.68 | 0 | |
Abbreviations: BMI, body mass index; NVB, neurovascular bundle; P/R, ratio of the cross-sectional areas of the prostate and the Retzius space.
The AUC of the ROC Curves for Factors Predictive of Prolonged LRP
| Parameters | AUC | 95% CI | P |
|---|---|---|---|
| Scoring system | 0.874 | 0.836–0.913 | <0.001 |
| BMI | 0.813 | 0.764–0.863 | <0.001 |
| Prostate volume | 0.823 | 0.774–0.871 | <0.001 |
| Pelvic lymph node dissection | 0.567 | 0.502–0.631 | 0.045 |
| NVB preservation | 0.615 | 0.552–0.678 | 0.001 |
| IPP | 0.792 | 0.740–0.844 | <0.001 |
| P/R | 0.782 | 0.730–0.834 | <0.001 |
Abbreviations: BMI, body mass index; IPP, intravesicular protrusion of the prostate; NVB, neurovascular bundle; P/R, ratio of the cross-sectional areas of the prostate and the Retzius space.
Figure 3(A) ROC curve analysis of the novel scoring system and other factors that were predictors of the duration of surgery; and (B) Hosmer–Lemeshow goodness-of-fit test results, showing good calibration for the scoring system (X2=5.339, P=0.376).
Figure 4External validation of the scoring system. (A) The novel scoring system achieved good predictive accuracy in the validation cohort. (B) The Hosmer–Lemeshow goodness-of-fit test also showed good calibration for the scoring system in this cohort (X2=4.401, P=0.493).